Stay updated on Pembrolizumab Combo in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page’s footer/revision version was updated (from 3.5.2 to 3.5.3) and the “Lung cancer” related topics section was (re)added/updated with MedlinePlus Genetics. These changes affect only site presentation/navigation rather than the clinical trial information itself.
    Difference
    0.1%
    Check dated 2026-04-24T05:48:28.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:24:12.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Removed the disease label 'Lung cancer' and the related topics section 'MedlinePlus Genetics' from the page.
    Difference
    0.1%
    Check dated 2026-04-09T21:30:41.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Lung cancer and MedlinePlus Genetics related topics were added.
    Difference
    0.1%
    Check dated 2026-04-02T15:28:26.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T05:10:51.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page now shows a new revision tag, v3.4.3, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T00:39:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page.